A method of treating cancer comprising a VEGF-B antagonist

Details for Australian Patent Application No. 2011265322 (hide)

Owner Zenyth Operations Pty Ltd

Inventors Nash, Andrew; Dunlop, Felicity Meredith; Baca, Manuel; Fabri, Louis Jerry; Scotney, David Pierre

Agent Davies Collison Cave

Pub. Number AU-A-2011265322

Parent 2005269265

Filing date 19 December 2011

Wipo publication date 19 January 2012

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 January 2012 Application Open to Public Inspection

  Published as AU-A-2011265322

19 January 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011265323-Methods and systems for deviceindependent media transactions

2011265321-Co-extruded marine sensor cable jacket with anti-fouling properties